Scoop: Famed cancer researcher — and biotech founder — Lew Cantley is headed to Dana-Farber
Lew Cantley, the famed cancer researcher best known for his discovery of the PI3K pathway and his groundbreaking work on cancer metabolism, is headed to Dana-Farber.
We got tipped off by someone at the institute that Cantley will make his move from Weill Cornell Medicine next February after Dana-Farber chief Laurie Glimcher sent out a note heralding his impending arrival as a faculty member in the Department of Cancer Biology. That puts the ex-Harvard professor right back in the center of things during an unprecedented biotech boom that has put Cambridge/Boston right at the epicenter of drug R&D.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 147,500+ biopharma pros reading Endpoints daily — and it's free.